Aureum Diagnostics

unknown
unknown
Stage

About

Aureum Diagnostics develops low-cost electrochemical biosensing platforms comprising a handheld connected instrument and single-use disposable test strips for point-of-care and biosafety testing. Their platform aims to deliver lateral-flow-like simplicity with PCR-level accuracy and the ability to detect multiple biomarkers from a single sample.

Explore Aureum Diagnostics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.